news

RIVERVIEW HEALTH NOW OFFERING MONOCLONAL ANTIBODY TREATMENT FOR HIGH RISK COVID-19 PATIENTS

RiverView Health is now offering monoclonal antibody treatment for those who have tested positive for COVID-19, are at high risk for progressing to severe COVID-19, and have certain risk factors, such as diabetes or heart disease that increases their risk of severe COVID-19 complications. This one-time, one-hour outpatient IV infusion treatment has proven to reduce […]

Share: